DE3773440D1 - Pharmazeutische zusammensetzungen fuer suppositorien. - Google Patents

Pharmazeutische zusammensetzungen fuer suppositorien.

Info

Publication number
DE3773440D1
DE3773440D1 DE8787108631T DE3773440T DE3773440D1 DE 3773440 D1 DE3773440 D1 DE 3773440D1 DE 8787108631 T DE8787108631 T DE 8787108631T DE 3773440 T DE3773440 T DE 3773440T DE 3773440 D1 DE3773440 D1 DE 3773440D1
Authority
DE
Germany
Prior art keywords
suppositories
pharmaceutical compositions
suppository
pharmaceutically acceptable
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787108631T
Other languages
English (en)
Inventor
Yamashita Chikamasa
Aza-Nishinosu Kouzo
Gohachiro Miyamoto
Ishikawa Muneyoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3773440D1 publication Critical patent/DE3773440D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/15Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8787108631T 1986-06-16 1987-06-16 Pharmazeutische zusammensetzungen fuer suppositorien. Expired - Lifetime DE3773440D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61141086A JPS62298530A (ja) 1986-06-16 1986-06-16 坐薬用医薬組成物

Publications (1)

Publication Number Publication Date
DE3773440D1 true DE3773440D1 (de) 1991-11-07

Family

ID=15283879

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787108631T Expired - Lifetime DE3773440D1 (de) 1986-06-16 1987-06-16 Pharmazeutische zusammensetzungen fuer suppositorien.

Country Status (10)

Country Link
US (1) US4784855A (de)
EP (1) EP0253143B1 (de)
JP (1) JPS62298530A (de)
AT (1) ATE67932T1 (de)
CA (1) CA1283605C (de)
DE (1) DE3773440D1 (de)
DK (1) DK167559B1 (de)
ES (1) ES2039377T3 (de)
IE (1) IE59668B1 (de)
PT (1) PT85086B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009066A1 (en) * 1988-03-24 1989-10-05 Bukh Meditec A/S Controlled release composition
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
JP2007016052A (ja) * 1998-03-03 2007-01-25 Eisai R & D Management Co Ltd 抗痴呆薬を含有した経皮適用製剤又は坐剤
AU2003297074A1 (en) * 2002-12-13 2004-07-09 Euro-Celtique S.A. Transdermal buprenorphine to treat pain in sickle cell crisis
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
US9415034B2 (en) * 2005-01-05 2016-08-16 National Defense Medical Center Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
CA2687979C (en) 2007-05-25 2017-07-04 Tolmar Therapeutics, Inc. Sustained delivery formulations of risperidone compounds
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
US20180250287A1 (en) * 2017-03-06 2018-09-06 Tactus Therapeutics, Inc. Abuse deterrent opioid formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870061A (en) * 1956-11-08 1959-01-20 Mead Johnson & Co Concentrates of dialkyl sulfosuccinates
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
US4004010A (en) * 1972-06-19 1977-01-18 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing an N-(furyl-methyl)-7α-acyl-6,14-(endoetheno or endoethano)-tetrahydro-nororipavine or -northebaine and method of use
DE2229770A1 (de) * 1972-06-19 1974-01-10 Boehringer Sohn Ingelheim N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
DE2230154A1 (de) * 1972-06-21 1974-01-17 Boehringer Sohn Ingelheim N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
JPS54157820A (en) * 1978-05-30 1979-12-13 Res Inst For Prod Dev Preparation of multi-layered suppository base
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
GB8332556D0 (en) * 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4699776A (en) * 1985-06-28 1987-10-13 R. P. Scherer Corporation Suppositories containing analgesics, antipyretics or anti-inflammatory agents

Also Published As

Publication number Publication date
EP0253143A2 (de) 1988-01-20
ES2039377T3 (es) 1993-10-01
EP0253143A3 (en) 1989-08-23
DK305087D0 (da) 1987-06-16
IE59668B1 (en) 1994-03-09
CA1283605C (en) 1991-04-30
US4784855A (en) 1988-11-15
JPS62298530A (ja) 1987-12-25
DK167559B1 (da) 1993-11-22
IE871522L (en) 1987-12-16
EP0253143B1 (de) 1991-10-02
PT85086B (pt) 1990-03-08
DK305087A (da) 1987-12-17
ATE67932T1 (de) 1991-10-15
PT85086A (en) 1987-07-01
JPH0475889B2 (de) 1992-12-02

Similar Documents

Publication Publication Date Title
IL82519A (en) Fibronolytic composition
FI871629A (fi) Segmenttipolyesteri, jossa on haarautuneita hydrofiilisiä pääteryhmiä ja sitä sisältävä detergenttikoostumus
ES541521A0 (es) Un procedimiento para la preparacion de piridazinaminas.
DE3773440D1 (de) Pharmazeutische zusammensetzungen fuer suppositorien.
UY23635A1 (es) Procedimiento para la preparacion de conjugados del peg interferon
SE8701348D0 (sv) Improvements in pharmaceutically acceptable salts
EG17753A (en) Novel pharmacological compounds
AU579012B2 (en) Compositions for the preparation of microparticles permitting a prolonged release of a biologically active substance
FI855117A (fi) Segmenttipolyestereitä ja niiden kaltaisia yhdisteitä käytettäviksi lianirrotusaineina pesuainekoostumuksissa
GR3004114T3 (de)
FI870457A (fi) Farmaceutiska preparatformer foer stabilisering av interferon.
ES2062375T3 (es) Composiciones farmaceuticas que contienen un complejo de zinc.
SE8404065D0 (sv) Novel biologically active compounds
SE8600658D0 (sv) Novel composition of matter
SE8302979L (sv) Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa
EP0380989A3 (en) Plaster for transdermal administration
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
ITMI912044A1 (it) Composizione farmaceutica solida per uso orale a base di dapiprazolo
IT1204778B (it) Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
IE873162L (en) Pesticidal compositions
MY100752A (en) Pharmaceutical composition for combating malaria.
IT1245390B (it) Composizione farmaceutica ad attivita' antivirale
DE3578172D1 (de) 2,5-pyrrolidindion-derivate mit antiarrhythmischer wirkung.
FI905922A0 (fi) Antagonister foer a-adrenerga receptorer.

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DER PATENTINHABER LAUTET RICHTIG: RECKITT & COLMAN PRODUCTS LTD., LONDON, GB

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: RECKITT & COLMAN PRODUCTS LTD., LONDON, GB

8327 Change in the person/name/address of the patent owner

Owner name: RECKITT BENCKISER HEALTHCARE (UK) LTD., SLOUGH, BE

8339 Ceased/non-payment of the annual fee